Gene: FHAD1
Official Full Name: forkhead associated phosphopeptide binding domain 1provided by HGNC
Gene Summary: Predicted to act upstream of or within apoptotic process and spermatogenesis. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO30728 | FHAD1 Knockout cell line (HCT 116) | Human | FHAD1 | 1:2~1:4 | Negative | Online Inquiry |
KO30729 | FHAD1 Knockout cell line (A549) | Human | FHAD1 | 1:3~1:4 | Negative | Online Inquiry |
FHAD1 Gene Knockout Cell Lines are advanced biological tools designed to facilitate in-depth investigations of the functions of the FHAD1 gene in cellular processes. These cell lines are engineered using CRISPR/Cas9 technology to create specific deletions within the FHAD1 gene, thereby providing researchers with a model to study the gene's role in various biological contexts.
The key function of these knockout cell lines is to elucidate the molecular mechanisms through which FHAD1 influences cellular behavior, particularly in metabolic regulation, cell proliferation, and apoptosis. By eliminating the expression of FHAD1, researchers can observe changes in downstream signaling pathways and gene expression profiles, leading to heightened understanding of the gene's role in normal and pathological states.
The scientific importance of FHAD1 Gene Knockout Cell Lines is evident in their applications across multiple research domains, including cancer biology, metabolic disorders, and regenerative medicine. This product enhances the capability of researchers to test hypotheses concerning gene function and investigate potential therapeutic targets linked to the FHAD1 gene.
What sets these cell lines apart from alternative products is their precision and reliability, bolstered by the rigorous validation procedures employed during their development. Unlike traditional knockout models, which can exhibit off-target effects and variable expression levels, the FHAD1 Gene Knockout Cell Lines ensure complete knockout, promoting reproducibility and accuracy in experimental outcomes.
For researchers and clinicians, these cell lines represent a valuable asset that can accelerate the discovery of new insights and therapeutic approaches. Furthermore, our company's dedication to cutting-edge biotechnological development and commitment to quality assurance makes us a trusted provider of superior biological products. Utilizing our FHAD1 Gene Knockout Cell Lines will not only streamline your research but also enhance your understanding of gene functionality in health and disease.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.